FDA Inspection
Robert A. Riesenberg, M.D.Robert A. Riesenberg, M.D. – FDA Inspection, Jun 17, 2019
Record Details
This FDA Inspection record concerns Robert A. Riesenberg, M.D., with an inspection on June 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 37e2749a-6375-494b-a54d-dd107ee4fd5b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1094120
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Robert A. Riesenberg, M.D.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2026 | Not classified | Atlanta District Office | |
| May 3, 2022 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| June 24, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 2, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert A. Riesenberg, M.D.
- FDA Inspection 1335296 - 2026-09-03
- FDA Inspection 1169440 - 2022-05-03
- FDA Inspection 1145517 - 2021-06-24
- FDA Inspection 1039883 - 2018-01-19
- FDA Inspection 914123 - 2015-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.